Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1759725 | 0.88 | TAAR1 (0.55) | TAAR1 | |
| SCHEMBL12647566 | 0.88 | TAAR1 (0.55) | TAAR1 | |
| SCHEMBL1759904 | 0.85 | — | — | |
| SCHEMBL1760165 | 0.85 | — | — | |
| SCHEMBL1760176 | 0.84 | — | — | |
| SCHEMBL1759863 | 0.84 | — | — | |
| SCHEMBL1760316 | 0.84 | — | — | |
| SCHEMBL1760380 | 0.84 | — | — | |
| SCHEMBL1759866 | 0.84 | — | — | |
| SCHEMBL1760382 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011057973-A1 | OXAZOLINE DERIVATIVES FOR TREATMENT OF CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2011-05-19 | — | — | WO | disclosed |